Figure 1.
Trial profile and patient flow.
Table 1.
Baseline characteristics by treatment strategy.
Figure 2.
Time to first AIDS event or death by treatment strategy.
A) Intensification versus standard antiretroviral therapy (ART); B) ART interruption versus continuation. Time to first non HIV-related serious adverse event (SAE) by C) intensification versus standard ART; D) ART interruption versus continuation.
Table 2.
AIDS events and death by treatment strategy.
Table 3.
First AIDS event or death by treatment strategy: stratified analysis.
Table 4.
First AIDS event or death by treatment strategy: unstratified, 2X2 factorial analysis (includes main effects interaction).
Table 5.
First AIDS event or death by treatment strategy and by follow-up time.
Table 6.
First AIDS event or death by treatment strategy and by calendar time.
Figure 3.
Immunological and virological changes over time by treatment strategy.
A) CD4 count change, intensification vs. standard antiretroviral therapy (ART); B) CD4 count change, ART interruption vs. continuation; C) HIV-1 viral load change, intensification vs. standard ART; D) HIV-1 viral load change, ART interruption vs. continuous.